• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脐疗联合艾灸治疗小儿秋季腹泻]

[Umbilical therapy combined with moxibustion for autumn diarrhea in children].

作者信息

Liu Xiao-Zhong, Zeng Zhao

机构信息

Basic Medical College, Guangzhou University of CM, Guangzhou 510000, Guangdong Province, China.

出版信息

Zhongguo Zhen Jiu. 2019 Aug 12;39(8):832-6. doi: 10.13703/j.0255-2930.2019.08.009.

DOI:10.13703/j.0255-2930.2019.08.009
PMID:31397127
Abstract

OBJECTIVE

To observe the efficacy differences between moxibustion combined with umbilical therapy and oral administration of montmorillonite powder (smecta) on diarrhea symptoms in children of different ages.

METHODS

A total of 120 children were randomly divided into an observation group and a control group, 60 cases in each group. In the observation group, the children aged under 3 years old were treated with moxibustion at Shenque (CV 8), Zhongwan (CV 12) and Tianshu (ST 25), and each acupoint was treated for less than 3 min, and the total treatment duration was no more than 10 min; the children aged between 3 to 7 years old were treated with moxibustion at Shenque (CV 8), Zhongwan (CV 12), Tianshu (ST 25), Guanyuan (CV 4), Zusanli (ST 36), Pishu (BL 20), Shenshu (BL 23) and Dachangshu (BL 25), each acupoint was treated for less than 3 min, and the total treatment duration was no more than 20 min. After moxibustion, traditional Chinese medicine patch (clove, cinnamon, rhizoma zingiberis, fructus evodiae, hawthorn, rhizoma atractylodis) was applied at Shenque (CV 8). For the children under 1 year old, the medical bag with 30 g powder was heated to 50 ℃ and used for about 30 min; for children over 1 year old, 2-5 g powder was mixed with vinegar and used for 4-8 h each time. The treatment was given once a day, three times as a course of treatment, and a total of one course of treatment was given. The children in the control group were treated with oral administration of montmorillonite powder, 3 g per day for children under 1 year old, 3-6 g per day for children aged 1-2 years old and 6-9 g per day for children over 2 years old. The montmorillonite powder was taken three times a day for 3 days. The diarrhea symptom scores before and after treatment were observed and the clinical efficacy was evaluated. From the first treatment, the recovery cases and recovery time in the two groups were recorded, the recovery cases and recovery time in acute and chronic stages were compared between different age groups. The recurrence was observed 3 months after treatment.

RESULTS

Compared before treatment, the diarrhea symptom score after treatment was decreased in the observation group (<0.05), while there was no significant difference before and after treatment in the control group (>0.05). After treatment, the score of diarrhea symptoms in the observation group was lower than that in the control group (<0.05). The total effective rate was 95.0% (57/60) in the observation group, which was superior to 76.7% (46/60) in the control group (<0.05). The recovery cases of acute stage aged ≤ 1 year old and 5-7 years old, and chronic stage of different age stages in the observation group was insignificantly higher than that in the control group (>0.05). The recovery time of different age stages and average recovery time in the observation group were shorter than those in the control group (<0.05). The recovery time of children in acute stage>1 year old and ≤5 years old and average recovery time in the observation group were shorter than those in the control group (<0.05), while the average recovery time of children in chronic stage in the observation group was shorter than that in the control group (<0.05). Three months after treatment, the recurrence rate was 0% (0/36) in acute phase and 4.8% (1/21) in chronic phase in the observation group, which were superior to 9.7% (3/31) in acute phase and 46.7% (7/15) in chronic phase in the control group (<0.05).

CONCLUSION

The umbilical therapy combined with moxibustion could improve the symptoms of diarrhea and shorten the recovery time in children of different ages with autumn diarrhea, which have better efficacy than montmorillonite powder.

摘要

目的

观察艾灸联合脐疗与口服蒙脱石散(思密达)对不同年龄段小儿腹泻症状的疗效差异。

方法

将120例患儿随机分为观察组和对照组,每组60例。观察组中,3岁以下患儿艾灸神阙(CV 8)、中脘(CV 12)和天枢(ST 25),每个穴位治疗时间少于3分钟,总治疗时间不超过10分钟;3至7岁患儿艾灸神阙(CV 8)、中脘(CV 12)、天枢(ST 25)、关元(CV 4)、足三里(ST 36)、脾俞(BL 20)、肾俞(BL 23)和大肠俞(BL 25),每个穴位治疗时间少于3分钟,总治疗时间不超过20分钟。艾灸后,在神阙(CV 8)处贴敷中药贴(丁香、肉桂、干姜、吴茱萸、山楂、苍术)。1岁以下患儿,将装有30克药粉的药袋加热至50℃,使用约30分钟;1岁以上患儿,每次将2 - 5克药粉与醋混合,使用4 - 8小时。每天治疗1次,3次为一个疗程,共给予一个疗程的治疗。对照组患儿口服蒙脱石散,1岁以下患儿每天3克,1 - 2岁患儿每天3 - 6克,2岁以上患儿每天6 - 9克。蒙脱石散每天服用3次,共服用3天。观察治疗前后的腹泻症状评分并评估临床疗效。从首次治疗开始,记录两组的痊愈病例及痊愈时间,比较不同年龄组急性和慢性阶段的痊愈病例及痊愈时间。治疗后3个月观察复发情况。

结果

与治疗前相比,观察组治疗后的腹泻症状评分降低(<0.05),而对照组治疗前后无显著差异(>0.05)。治疗后,观察组的腹泻症状评分低于对照组(<0.05)。观察组总有效率为95.0%(57/60),优于对照组的76.7%(46/60)(<0.05)。观察组≤1岁和5 - 7岁急性阶段以及不同年龄阶段慢性阶段的痊愈病例略高于对照组(>0.05)。观察组不同年龄阶段的痊愈时间及平均痊愈时间均短于对照组(<0.05)。观察组>1岁且≤5岁急性阶段患儿的痊愈时间及平均痊愈时间短于对照组(<0.05),而观察组慢性阶段患儿的平均痊愈时间短于对照组(<0.05)。治疗后3个月,观察组急性期复发率为0%(0/36),慢性期为4.8%(1/21),均优于对照组急性期的9.7%(3/31)和慢性期的46.7%(7/15)(<0.05)。

结论

艾灸联合脐疗可改善不同年龄段小儿秋季腹泻的症状,缩短痊愈时间,疗效优于蒙脱石散。

相似文献

1
[Umbilical therapy combined with moxibustion for autumn diarrhea in children].[脐疗联合艾灸治疗小儿秋季腹泻]
Zhongguo Zhen Jiu. 2019 Aug 12;39(8):832-6. doi: 10.13703/j.0255-2930.2019.08.009.
2
[Clinical study of medicinal-cake-separated moxibustion for senile osteoporosis].隔药饼灸治疗老年性骨质疏松症的临床研究
Zhongguo Zhen Jiu. 2017 May 12;37(5):473-476. doi: 10.13703/j.0255-2930.2017.05.005.
3
[Clinical observation on drug-separated moxibustion at Shenque (CV 8) for treatment of infantile autumn diarrhea].隔药灸神阙穴(CV 8)治疗婴幼儿秋季腹泻的临床观察
Zhongguo Zhen Jiu. 2008 Mar;28(3):194-6.
4
[Adjuvant therapy of moxibustion combined with formula for peritoneal effusion of ovarian malignant tumors].艾灸联合方剂对卵巢恶性肿瘤腹水的辅助治疗
Zhongguo Zhen Jiu. 2019 Dec 12;39(12):1294-8. doi: 10.13703/j.0255-2930.2019.12.010.
5
[Effect on follicular development and pregnancy outcome treated with acupuncture and moxibustion therapy of in patients with luteal phase defect].[针刺艾灸疗法对黄体期缺陷患者卵泡发育及妊娠结局的影响]
Zhongguo Zhen Jiu. 2019 Sep 12;39(9):927-31. doi: 10.13703/j.0255-2930.2019.09.004.
6
[Efficacy of acupoint catgut embedding combined with ginger-partitioned moxibustion on chronic fatigue syndrome of spleen-kidney deficiency syndrome and its effects on T lymphocyte subsets and activity of NK cell].穴位埋线联合隔姜灸治疗脾肾两虚型慢性疲劳综合征的疗效及其对T淋巴细胞亚群和NK细胞活性的影响
Zhongguo Zhen Jiu. 2017 Aug 12;37(8):814-818. doi: 10.13703/j.0255-2930.2017.08.004.
7
[Observation of long-term efficacy and life quality in allergic rhinitis treated with acupoint catgut embedding therapy combined with acupuncture-moxibustion therapy].穴位埋线联合针灸疗法治疗变应性鼻炎的远期疗效及生活质量观察
Zhongguo Zhen Jiu. 2014 May;34(5):439-43.
8
[Effects of moxibustion on immune function in children with cerebral palsy].
Zhongguo Zhen Jiu. 2016 Jan;36(1):12-6.
9
Effect of warming moxibustion on Shenque acupoint for the treatment of acute diarrhea in children with infantile cerebral palsy.温灸神阙穴治疗小儿脑瘫腹泻急性发作的疗效观察
Chin J Integr Med. 2009 Dec;15(6):454-7. doi: 10.1007/s11655-009-0454-8. Epub 2010 Jan 18.
10
[Herbal-moxa plaster for diarrhea type irritable bowel syndrome of spleen and kidney deficiency: a randomized controlled trial].[中药艾灸贴治疗脾肾阳虚型腹泻型肠易激综合征:一项随机对照试验]
Zhongguo Zhen Jiu. 2023 Jun 12;43(6):617-21. doi: 10.13703/j.0255-2930.20220804-k0001.

引用本文的文献

1
Non-pharmacological management of pediatric functional abdominal pain disorders: Current evidence and future perspectives.小儿功能性腹痛疾病的非药物治疗:当前证据与未来展望
World J Clin Pediatr. 2022 Mar 9;11(2):105-119. doi: 10.5409/wjcp.v11.i2.105.
2
Moxibustion for diarrhea in children: A protocol for systematic review and meta-analysis.艾灸治疗小儿腹泻:系统评价和荟萃分析方案。
Medicine (Baltimore). 2021 Apr 30;100(17):e25712. doi: 10.1097/MD.0000000000025712.